NeuroPace Inc (NPCE)
| Market Cap | 437.98M+19.8% |
| Revenue (ttm) | 106.99M |
| Net Income | -16.17M |
| EPS | -0.57 |
| Shares Out | 34.32M |
| PE Ratio | n/a |
| Forward PE | -58.67 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 127,170 |
| Open | 12.58 |
| Previous Close | 12.67 |
| Day's Range | 12.58 - 13.06 |
| 52-Week Range | 9.22 - 19.60 |
| Beta | 1.87 |
| Analysts | none |
| Price Target | 20.00(+56.74%) |
| Earnings Date | Nov 3, 2026 |
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About NPCE
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
$NPCE stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in NPCE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NPCE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NPCE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New NPCE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NPCE from public contracts
Source: USAspending.gov
NPCE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from NPCE’s recent data — informational, not investment advice